Park Ave Center INC

Park Ave Center INC was paid $50.83M by Medicaid between Jan 2018 and Dec 2024, across 6 billing codes. Its largest line is H2035, Alcohol and/or other drug treatment program, per hour — 94% of everything it billed.

33Billing provider infoPARK AVE CENTER INC
MINNEAPOLIS, MN 55404

33aNPI1720154081assigned 11/28/2006

33bProvider typeClinical Medical Laboratory

28Total paid$50.83M

24GClaims366,150

24DCodes billed6

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in Minnesota

Rank by total paid#1 of 69

Median peer was paid$48K

This provider vs. median1,054×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	59,737	$3.34M
2019	68,493	$9.14M
2020	57,858	$8.19M
2021	46,909	$7.72M
2022	47,457	$7.74M
2023	47,067	$8.13M
2024incomplete	38,629	$6.57M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
H2035	Alcohol and/or other drug treatment program, per hour	94%	329,390	22,207	$47.76M
H0001	Alcohol and/or drug assessment	5.2%	20,509	19,264	$2.65M
H0038	Self-help/peer services, per 15 minutes	<1%	4,715	3,318	$173K
T1016	Case management, each 15 minutes	<1%	9,111	4,543	$132K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,147	1,276	$119K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	278	180	$8K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCASAGRANDE, LINDA (CFO)